Johnson & Johnson submits application to the European
Submission is supported by data from the Phase 3 PALOMA-3 study featured at the American Society of Clinical Oncology (ASCO) ...
Read moreSubmission is supported by data from the Phase 3 PALOMA-3 study featured at the American Society of Clinical Oncology (ASCO) ...
Read moreHOCKLEY, Texas, May 01, 2024 (GLOBE NEWSWIRE) -- Jasco, lighting and connected home leader, recently announced a unique partnership at ...
Read moreJohnson & Johnson marks new era in the UK with updated visual identity High Wycombe, UK, May 01, 2024 (GLOBE ...
Read moreThis positive CHMP opinion establishes amivantamab as a new option, and the first fully-human EGFR-MET bispecific antibody, in the first-line ...
Read moreSOLANA BEACH, Calif., March 12, 2024 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling ...
Read more© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.
© 2015 - 2024 LifeCare News - LIFE CARE IS REGISTERED MAGAZINE IN RNI, NO.GUJGUJ/2015/71283 - Lifecarenews.in.